Suppression of mTOR Signaling by miR-302/367 Cluster in Breast Cancer Cells

Mahsa Alemi1, Masoumeh Fakhr Taha1, Arezoo Bazargani1

  • 1Department of Stem Cells and Regenerative Medicine, Institute for Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Insights

The miR-302/367 cluster suppresses tumors by inhibiting the mTOR pathway in breast cancer cells. This microRNA cluster targets key mTOR regulators, reducing their expression and slowing cancer cell growth.

Area of Science:

  • Molecular biology
  • Cancer research
  • Biochemistry

Background:

  • The mechanistic target of rapamycin (mTOR) signaling pathway regulates critical cellular processes like protein synthesis and metabolism.
  • Aberrant mTOR signaling is frequently observed in various cancers.
  • The miR-302/367 microRNA cluster has demonstrated tumor-suppressive properties.

Purpose of the Study:

  • To investigate the impact of miR-302/367 cluster overexpression on mTOR signaling in cancer cells.
  • To identify and validate direct targets of miR-302/367 within the mTOR pathway.
  • To elucidate the molecular mechanisms underlying the tumor-suppressive effects of miR-302/367.

Main Methods:

  • Bioinformatic analysis to predict miR-302/367 targets in the mTOR pathway.
  • Dual-luciferase reporter assays to confirm direct targeting of PIK3CB, RRAGD, and FNIP1.
  • Gene and protein expression analysis in breast cancer cell lines (SK-BR-3, MDA-MB-231) after miR-302/367 transfection.
  • Cell proliferation assays.

Main Results:

  • PIK3CB, RRAGD, and FNIP1 were validated as direct targets of the miR-302/367 cluster.
  • Overexpression of miR-302/367 led to decreased transcript and protein levels of PIK3CB, RRAGD, and FNIP1.
  • miR-302/367 transfection inhibited breast cancer cell proliferation.
  • Downregulation of multiple mTOR pathway components was observed, indicating a broad inhibitory effect.

Conclusions:

  • The miR-302/367 cluster exerts tumor-suppressive effects in breast cancer by modulating mTOR signaling at multiple levels.
  • This microRNA cluster directly targets key components of the mTOR pathway, including PIK3CB, RRAGD, and FNIP1.
  • The findings suggest therapeutic potential for the miR-302/367 cluster in cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K